40
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Ryanodine Receptor-Mediated Ca 2+ Events in Atrial Myocytes of Patients with Atrial Fibrillation

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Many alterations in sarcoplasmic reticulum Ca<sup>2+</sup> handling proteins in atrial myocytes have been associated with atrial fibrillation (AF) in clinical patients, whereas the functional consequences of these alterations mostly remain unclear. Methods and Results: To know whether or not ryanodine receptor (RyR)-mediated intracellular Ca<sup>2+</sup> events in AF atrial myocytes are affected by protein alterations, we investigated spontaneous Ca<sup>2+</sup> sparks and Ca<sup>2+</sup> waves in intact and permeabilized atrial myocytes of AF patients (n<sub>patients</sub> = 21) and normal sinus rhythm (NSR) patients (n<sub>patients</sub> = 22) by laser scanning confocal microscopy. It was found that the frequency, amplitude and rise time of Ca<sup>2+</sup> sparks were comparable between AF and NSR groups, while full width and full duration at half maximum intensity significantly increased in the AF group. Along with these changes, the frequency of small and global Ca<sup>2+</sup> waves increased in AF atrial myocytes. Conclusions: Our results clearly indicated that the spatiotemporal properties but not the frequency of Ca<sup>2+</sup> sparks were affected in AF atrial myocytes. In addition, the frequency of Ca<sup>2+</sup> waves increased. This profile of the alterations in RyR-mediated Ca<sup>2+</sup> events in AF atrial myocytes was different from previous studies. The underlying mechanisms, as well as possible reasons for this discrepancy, were discussed.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Electrical, contractile and structural remodeling during atrial fibrillation.

          The natural history of atrial fibrillation (AF) is characterized by a gradual worsening with time. The recent finding that AF itself produces changes in atrial function and structure has provided a possible explanation for the progressive nature of this arrhythmia. Electrical remodeling (shortening of atrial refractoriness) develops within the first days of AF and contributes to an increase in stability of AF. However, 'domestication of AF' must also depend on a 'second factor' since the persistence of AF continues to increase after electrical remodeling has been completed. Atrial contractile remodeling (loss of contractility) leads to a reduced atrial transport function after cardioversion of AF. An important clinical consequence is that during several days after restoration of sinus rhythm, the risk of atrial thrombus formation is still high. In addition, the reduction of atrial contractility during AF may enhance atrial dilatation which may add to the persistence of AF. Tachycardia-induced structural remodeling takes place in a different time domain (weeks to months). Myolysis probably contributes to the loss of atrial contractile force. Although it might explain the loss of efficacy of pharmacological cardioversion and the development of permanent AF, the role of structural remodeling in the progression of AF is still unclear. Atrial structural remodeling also occurs as a result of heart failure and other underlying cardiovascular diseases. The associated atrial fibrosis might explain intra-atrial conduction disturbances and the susceptibility for AF. Thus, both AF itself and the underlying heart disease are responsible for the development of the arrhythmogenic substrate. New strategies for prevention and termination of AF should be build on our knowledge of the mechanisms and time course of AF-induced atrial remodeling.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes.

              Spontaneous Ca2+ release from the sarcoplasmic reticulum (SR) can generate afterdepolarizations, and these have the potential to initiate arrhythmias. Therefore, an association may exist between spontaneous SR Ca2+ release and initiation of atrial fibrillation (AF), but this has not yet been reported. Spontaneous Ca2+ release from the SR, manifested as Ca2+ sparks and Ca2+ waves, was recorded with confocal microscopy in atrial myocytes isolated from patients with and those without AF. In addition, the spontaneous inward current associated with Ca2+ waves was measured with the use of the perforated patch-clamp technique. The Ca2+ spark frequency was higher in 8 patients with AF than in 16 patients without (6.0+/-1.2 versus 2.8+/-0.8 sparks/mm per second, P<0.05). Similarly, the spontaneous Ca2+ wave frequency was greater in patients with AF (2.8+/-0.5 versus 1.1+/-0.3 waves/mm per second, P<0.01). The spontaneous inward current frequency was also higher in 10 patients with AF than in 13 patients without this arrhythmia (0.101+/-0.028 versus 0.031+/-0.007 per second, P<0.05, at a clamped potential of -80 mV). In contrast, both the Ca2+ released from the SR and the Na+-Ca2+ exchange rate induced by a rapid caffeine application were comparable in patients with and without AF. The observed increase in spontaneous Ca2+ release in patients with AF probably is due to an upregulation of the SR Ca2+ release channel activity, which may contribute to the development of AF.
                Bookmark

                Author and article information

                Journal
                CRD
                Cardiology
                10.1159/issn.0008-6312
                Cardiology
                S. Karger AG
                0008-6312
                1421-9751
                2008
                August 2008
                31 March 2008
                : 111
                : 2
                : 102-110
                Affiliations
                aBio-X Life Science Research Center, College of Life Science and Biotechnology, Shanghai Jiao Tong University, bUnit of Cell Signal Transduction, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, cDepartment of Cardiac Surgery and Shanghai Institute of Cardiovascular Disease, Zhong Shan Hospital, Fu Dan University, and dShanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China
                Article
                119697 Cardiology 2008;111:102–110
                10.1159/000119697
                18376121
                eb60cf05-6949-42bb-ac72-2e21e173fcd7
                © 2008 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 05 August 2007
                : 31 October 2007
                Page count
                Figures: 4, Tables: 1, References: 25, Pages: 9
                Categories
                Original Research

                General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
                Atrial fibrillation,Ryanodine receptor,Ca2+ sparks,Sarcoplasmic reticulum,Ca2+ waves

                Comments

                Comment on this article